KIF22 and esophageal squamous cell carcinoma: Recent research suggests that the Kinesin Family Member 22 (KIF22)/miR-122 axis might serve as a biomarker for esophageal squamous cell carcinoma (ESCC) by reducing miR-122 levels, inhibiting the KIF22-mediated growth of ESCC cells [35].